ÿþ<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml" > <head> <title>Cedocore</title> <link rel="stylesheet" type="text/css" href="css/global.css" /> <style type="text/css"> p{ font-family:Arial; font-size:12px; color:Black; } div{ font-family:Arial; font-size:12px; color:Black; } </style> </head> <body style="background-image:url(images/side.jpg); background-repeat:repeat;"> <table cellpadding="0" cellspacing="0"> <tr> <td style="background-image:url(images/rswtb_01.jpg); height:72px; width:800px;"></td> </tr> <tr> <td style="background-image:url(images/rswtb_02.jpg); height:422px; width:800px;"></td> </tr> <tr> <td style="background-image:url(images/rswtb_03.jpg); height:326px; width:800px;"> </tr> <tr> <td> <table cellpadding="0" cellspacing="0"> <tr> <td><img alt="" src="images/rswtb_04.jpg" /></td><td><img alt="" src="images/rswtb_05.jpg" /></td> </tr> </table> </td> </tr> <tr> <td style="background-image:url(images/rswtb_06.jpg); height:356px; width:800px;"></td> </tr> <tr> <td> <table cellpadding="0" cellspacing="0"> <tr> <td style="background-image:url(images/rswtb_07.jpg); height:280px; width:247px;"></td> <td><img alt="" src="images/rswtb_08.jpg" /></td> <td style="background-image:url(images/rswtb_09.jpg); height:280px; width:275px;"></td> </tr> </table> </td> </tr> <tr> <td style="background-image:url(images/rswtb_10.jpg); height:378px; width:800px;"></td> </tr> <tr> <td style="background-image:url(images/rswtb_11.jpg); height:338px; width:800px;"></td> </tr> </table> <div style="position:absolute; top:7px; left:228px; font-size:55px; font-weight:bold;">TOP SECR ET</div> <div style="position:absolute; top:107px; left:182px; font-size:18px; font-weight:bold;">R<span class="leftUp">apport St</span>ratégique par Wantzen-Tabard-Boutier</div> <div style="position:absolute; top:162px; left:185px; font-size:46px; font-weight:bold;">Hycephamitamyn-·</div> <div style="position:absolute; top:239px; left:233px; font-size:13px; font-weight:bold; text-align:center;"><span style="font-weight:normal; font-size:12px;">PRESENTE D BY</span><br /> WANTZEN-TABARD-BOUTIER PHARMACEUTICAL CO.<br /> IN COOPERATION WITH CEDOCORE CORP. </div> <div style="position:absolute; top:336px; left:8px; font-size:12px;"> <i>Clinical syno<span class="one">psis based on one 12-w</span><!--eek, double-blind, placebo-controlled Phase III study with a population of 1206 patients.--></i> <br /><br /><br /> <span style="font-weight:bold; font-size:14px;">EXEMPTED FROM IEC EVALUATION<br /> BY P<span class="three">RESIDE</span><!--NTIAL ORDER--></span> <br /><br /><br /> <span style="font-size:24px; font-weight:bold;">I. CLINICAL SYNOPSIS</span> <br /><br /> Hycephamitamyn-· is the wor<span class="two">king name for the a</span><!--ctive ingredient in a drug developed by WTB for inclusion in the Cedocore portfolio.--> <br /><br /> <span style="font-weight:bold; font-size:14px;">Metho<span class="left">ds of Admin</span>istration</span> <br /> In its liquid form, the drug may be administered via injection, inhalation or eye drops. It is distri<span class="leftUp">buted in a one-use i</span>njection vial which <br /> eliminates t<span class="left">he need for syr</span>inge and reduces the complications of both pro<span class="one">curement and shari</span><!--ng. Inhalation and eye drops are --><br /> comfortable and immediately effective me<span class="two">thods. The drug may b</span><!--e swallowed as a pill or as a sweetened  candy powder (with --><br /> particular appeal to adolescent users), or inhaled as a powder (with particular appeal to ol<span class="leftUp">der users due to paral</span>lels with old-style <br /> cocaine ingesti<span class="three">on). In certain re</span><!--sidue preparations, the drug may be absorbed through the skin, particularly fingers and lips. It may --><br /> also be smoked, although this method ranked lowest in appeal in focus group studies. <br /><br /> <span style="font-weight:bold; font-size:14px;">Effects and React ions</span> <br /><br /> Desired effects produced by th<span class="leftUp">e drug inc</span>lude:<br /> <span style="padding-left:25px;">" euph oria</span><br /> <span style="padding-left:25px;">" lethargy</span><br /> <span style="padding-left:25px;">" hallucinations</span> <br /><br /> I<span class="one">ngestion of the drug v</span><!--ia eyedrops results in a temporary blacking of the sclera, providing a convenient marker for law-enforcement to --><br /> identify persistent users. </div> <div style="position:absolute; top:1106px; left:8px; font-size:12px;"> <span style="font-weight:bold; font-size:14px;">Carc<span class="two">inogene</span><!--sis and Mutagenesis--></span> <br /> Based on a 72-week carcinogen<span class="leftUp">icity study in CD-1 </span>mice, hycephamitamyn variants have consistently show<span class="two">n an increased inc</span><!--idence of --><br /> some types of benign gr<span class="leftUp">owths at moderate dosage l</span>evels and a mildly increased incidence of some types of cancer at high dosage <br /> levels. <br /><br /> <span style="font-weight:bold; font-size:14px;">Overdosage</span> <br /> Three instances of significant overdosage duri<span class="two">ng the trial resulte</span><!--d in one mortality (myocardial infarction subsequent to ingestion of 18--> <br /> times maximum recommend<span class="three">ed dosage). Due to increased lethar</span><!--gy at increased dosages, overdose is not considered a high risk --><br /> factor. <br /><br /><br /><br /> <span style="font-weight:bold; font-size:24px;">II. BUSINESS SYNOPSIS & STRAT<span class="left">EGIC OVER</span>VIEW</span> <br /><br /><br /> Illegal drug imports have been dropping internationally due to climate change and polit<span class="leftUp">ical factors. We are poi</span>sed to captur e that <br /> mar<span class="left">ket share with a drug who</span>se manufacture is closely controlled and which prod<span class="one">uces desired effects in u</span><!--sers, including sedation and --><br /> suggestibility. <br /><br /> Total revenue from release of hycephamitamyn-· int<span class="leftUp">o the domestic and in</span>ternational black market is expected to rise slowly, but with a <br /> high rate of return thanks to superior market control and high profit margin. Ten-year project<span class="two">ions can be seen i</span><!--n Figure 3.--> </div> <div style="position:absolute; top:1769px; left:8px; font-size:12px;"> <span style="font-weight:bold; font-size:14px;">Marketing:  Street vs OTC</span><br /> There has been som<span class="leftUp">e internal resistance to tak</span>ing an aggressive approach to productizing this compound at the s<span class="one">treet level. Wh</span><!--ile--> <br /> everyone agrees there are profits to be made, arguments agai<span class="two">nst marketing this drug on </span><!--the street usually center on the feeling that --><br />  Cedocore should not be encouraging  illegal behavior. This leads naturally to two suggestions: <br /><br /> <span style="padding-left:25px;">" Find a medical fig-leaf (e.g. the  tonic benefit of the cocaine originally in Coca-Cola);</span><br /> <span style="padding-left:25px;">" Pro<span class="leftUp">ductize hycephamita</span>myn-· as a legal, OTC drug, like alcohol or nicotine.</span><br /> <br /><br /> These suggestions, th<span class="one">ough well-meant, do n</span><!--ot fit Cedocore s long-range strategic planning. To whit:--> <br /><br /> <span class="three">Cedocore has recently brokered an allia</span><!--nce with several major players in the  street drug distribution chain. Although all parties can --><br /> see the potential value of this alliance, there is the natural wariness attendant on all s<span class="left">uch ventures at their out</span>set. To put it bluntly, <br /> having entered into partnership wit<span class="one">h this sales force, we nee</span><!--d to give them a product to sell that matches their existing consumer base.--> <br /><br /> The  black market or  illegal consumer also has some marked advantages over his OTC counterpart. <br /><br /> <span style="padding-left:25px;">" The product is perceived as  cooler and  more intense than an OTC counterpart which is assumed to have be en  neutered by</span><br /> <span style="padding-left:33px;">the FDA, etc.</span><br /> <span style="padding-left:25px;">" Ille<span class="three">gal drug users are less likely to question </span><!--profit margins or price increases.--></span><br /> <span style="padding-left:25px;">" Illegal drug users cannot bring class action lawsuits for side-effects, emotional trauma, carcinogenicity, etc.</span> <br /><br /> Lastly, there is a moral argument. Illegal drug users, like the poor, will be with us always. They are going to buy product from <br /> someone: why not us? Our quality control and testi<span class="leftUp">ng are infinitely superior to t</span>heir previous suppliers. <br /><br /> Instead of funding street gangs and urban warlordism, the profits from hycephamitamyn-· can help support not only Cedocore (80,000 <br /> law-abiding employees worldwide) but can fund the corporate-political consortium in which Cedocore so proudly plays a part. <br /><br /> <span style="font-weight:bold; font-size:14px;">Hycephamitamyn and Law Enforcement</span><br /> We on the development team are extremely bullish on the potential synergy between Cedoc<span class="two">ore s new  street sales te</span><!--am and law --><br /> enforce<span class="one">ment. Having a  hot new trip a</span><!--s our product line gives our sales force an automatic entry into  dissident or  subversive --><br /> sub-cultures that would be difficult for regular l<span class="leftUp">aw enforcement to pen</span>etrate. <br /><br /> Contacts in the DoJ are already formu<span class="one">lating policy directives that w</span><!--ill ask local law enforcement to turn a blind eye to hycephamitamyn-· --><br /> trafficking, in exchange for leads on dissidents and ot<span class="leftUp">her kinds of domesti</span>c terrorism. <br /><br /> In short, we believe that Cedocore s inv<span class="leftUp">estment in hyceph</span>amitamyn-· will be seen as a watershed moment in corporate history. <br /> Tactically, hycephamitamyn-· figures to have a long, strong lifetime as a profit-margin winner. Ev<span class="one">en more important, howe</span><!--ver, is --><br /> the strategic benefit of turning the chaotic violence of the black market into a safer, more stable platform for long-term business <br /> development. </div> <div style="position:absolute; top:7px; left:228px; font-size:55px; font-weight:bold;">TOP SECRET</div> <div style="position:absolute; top:107px; left:182px; font-size:18px; font-weight:bold;">Rapport Stratégique par Wantzen-Tabard-Boutier</div> <div style="position:absolute; top:162px; left:185px; font-size:46px; font-weight:bold;">Hycephamitamyn-·</div> <div style="position:absolute; top:239px; left:233px; font-size:13px; font-weight:bold; text-align:center;"><span style="font-weight:normal; font-size:12px;">PRESENTED BY</span><br /> WANTZEN-TABARD-BOUTIER PHARMACEUTICAL CO.<br /> IN COOPERATION WITH CEDOCORE CORP. </div> <div style="position:absolute; top:336px; left:8px; font-size:12px;"> <i>Clinical synopsis based on one 12-week, double-blind, placebo-controlled Phase III study with a population of 1206 patients.</i> <br /><br /><br /> <span style="font-weight:bold; font-size:14px;">EXEMPTED FROM IEC EVALUATION<br /> BY PRESIDENTIAL ORDER</span> <br /><br /><br /> <span style="font-size:24px; font-weight:bold;">I. CLINICAL SYNOPSIS</span> <br /><br /> Hycephamitamyn-· is the working name for the active ingredient in a drug developed by WTB for inclusion in the Cedocore portfolio. <br /><br /> <span style="font-weight:bold; font-size:14px;">Methods of Administration</span> <br /> In its liquid form, the drug may be administered via injection, inhalation or eye drops. It is distributed in a one-use injection vial which <br /> eliminates the need for syringe and reduces the complications of both procurement and sharing. Inhalation and eye drops are <br /> comfortable and immediately effective methods. The drug may be swallowed as a pill or as a sweetened  candy powder (with <br /> particular appeal to adolescent users), or inhaled as a powder (with particular appeal to older users due to parallels with old-style <br /> cocaine ingestion). In certain residue preparations, the drug may be absorbed through the skin, particularly fingers and lips. It may <br /> also be smoked, although this method ranked lowest in appeal in focus group studies. <br /><br /> <span style="font-weight:bold; font-size:14px;">Effects and Reactions</span> <br /><br /> Desired effects produced by the drug include:<br /> <span style="padding-left:25px;">" euphoria</span><br /> <span style="padding-left:25px;">" lethargy</span><br /> <span style="padding-left:25px;">" hallucinations</span> <br /><br /> Ingestion of the drug via eyedrops results in a temporary blacking of the sclera, providing a convenient marker for law-enforcement to <br /> identify persistent users. </div> <div style="position:absolute; top:1106px; left:8px; font-size:12px;"> <span style="font-weight:bold; font-size:14px;">Carcinogenesis and Mutagenesis</span> <br /> Based on a 72-week carcinogenicity study in CD-1 mice, hycephamitamyn variants have consistently shown an increased incidence of <br /> some types of benign growths at moderate dosage levels and a mildly increased incidence of some types of cancer at high dosage <br /> levels. <br /><br /> <span style="font-weight:bold; font-size:14px;">Overdosage</span> <br /> Three instances of significant overdosage during the trial resulted in one mortality (myocardial infarction subsequent to ingestion of 18 <br /> times maximum recommended dosage). Due to increased lethargy at increased dosages, overdose is not considered a high risk <br /> factor. <br /><br /><br /><br /> <span style="font-weight:bold; font-size:24px;">II. BUSINESS SYNOPSIS & STRATEGIC OVERVIEW</span> <br /><br /><br /> Illegal drug imports have been dropping internationally due to climate change and political factors. We are poised to capture that <br /> market share with a drug whose manufacture is closely controlled and which produces desired effects in users, including sedation and <br /> suggestibility. <br /><br /> Total revenue from release of hycephamitamyn-· into the domestic and international black market is expected to rise slowly, but with a <br /> high rate of return thanks to superior market control and high profit margin. Ten-year projections can be seen in Figure 3. </div> <div style="position:absolute; top:1769px; left:8px; font-size:12px;"> <span style="font-weight:bold; font-size:14px;">Marketing:  Street vs OTC</span><br /> There has been some internal resistance to taking an aggressive approach to productizing this compound at the street level. While <br /> everyone agrees there are profits to be made, arguments against marketing this drug on the street usually center on the feeling that <br />  Cedocore should not be encouraging  illegal behavior. This leads naturally to two suggestions: <br /><br /> <span style="padding-left:25px;">" Find a medical fig-leaf (e.g. the  tonic benefit of the cocaine originally in Coca-Cola);</span><br /> <span style="padding-left:25px;">" Productize hycephamitamyn-· as a legal, OTC drug, like alcohol or nicotine.</span><br /> <br /><br /> These suggestions, though well-meant, do not fit Cedocore s long-range strategic planning. To whit: <br /><br /> Cedocore has recently brokered an alliance with several major players in the  street drug distribution chain. Although all parties can <br /> see the potential value of this alliance, there is the natural wariness attendant on all such ventures at their outset. To put it bluntly, <br /> having entered into partnership with this sales force, we need to give them a product to sell that matches their existing consumer base. <br /><br /> The  black market or  illegal consumer also has some marked advantages over his OTC counterpart. <br /><br /> <span style="padding-left:25px;">" The product is perceived as  cooler and  more intense than an OTC counterpart which is assumed to have been  neutered by</span><br /> <span style="padding-left:33px;">the FDA, etc.</span><br /> <span style="padding-left:25px;">" Illegal drug users are less likely to question profit margins or price increases.</span><br /> <span style="padding-left:25px;">" Illegal drug users cannot bring class action lawsuits for side-effects, emotional trauma, carcinogenicity, etc.</span> <br /><br /> Lastly, there is a moral argument. Illegal drug users, like the poor, will be with us always. They are going to buy product from <br /> someone: why not us? Our quality control and testing are infinitely superior to their previous suppliers. <br /><br /> Instead of funding street gangs and urban warlordism, the profits from hycephamitamyn-· can help support not only Cedocore (80,000 <br /> law-abiding employees worldwide) but can fund the corporate-political consortium in which Cedocore so proudly plays a part. <br /><br /> <span style="font-weight:bold; font-size:14px;">Hycephamitamyn and Law Enforcement</span><br /> We on the development team are extremely bullish on the potential synergy between Cedocore s new  street sales team and law <br /> enforcement. Having a  hot new trip as our product line gives our sales force an automatic entry into  dissident or  subversive <br /> sub-cultures that would be difficult for regular law enforcement to penetrate. <br /><br /> Contacts in the DoJ are already formulating policy directives that will ask local law enforcement to turn a blind eye to hycephamitamyn-· <br /> trafficking, in exchange for leads on dissidents and other kinds of domestic terrorism. <br /><br /> In short, we believe that Cedocore s investment in hycephamitamyn-· will be seen as a watershed moment in corporate history. <br /> Tactically, hycephamitamyn-· figures to have a long, strong lifetime as a profit-margin winner. Even more important, however, is <br /> the strategic benefit of turning the chaotic violence of the black market into a safer, more stable platform for long-term business <br /> development. </div> </body> </html>